Abstract:Aims: Cardiac sympathetic overactivation is an important trigger of ventricular arrhythmias in patients with chronic heart failure (CHF). Our previous study demonstrated that N-type calcium (Cav2.2) currents in cardiac sympathetic post-ganglionic (CSP) neurons were increased in CHF. This study investigated the contribution of Cav2.2 channels in cardiac sympathetic overactivation and ventricular arrhythmogenesis in CHF. Methods and results: Rat CHF was induced by surgical ligation of the left coronary artery. Lentiviral Cav2.2-α shRNA or scrambled shRNA was transfected in vivo into stellate ganglia (SG) in CHF rats. Final experiments were performed at 14 weeks after coronary artery ligation. Real-time polymerase chain reaction and western blot data showed that in vivo transfection of Cav2.2-α shRNA reduced the expression of Cav2.2-α mRNA and protein in the SG in CHF rats. Cav2.2-α shRNA also reduced Cav2.2 currents and cell excitability of CSP neurons and attenuated cardiac sympathetic nerve activities (CSNA) in CHF rats. The power spectral analysis of heart rate variability (HRV) further revealed that transfection of Cav2.2-α shRNA in the SG normalized CHF-caused cardiac sympathetic overactivation in conscious rats. Twenty-four-hour continuous telemetry electrocardiogram recording revealed that this Cav2.2-α shRNA not only decreased incidence and duration of ventricular tachycardia/ventricular fibrillation but also improved CHF-induced heterogeneity of ventricular electrical activity in conscious CHF rats. Cav2.2-α shRNA also decreased susceptibility to ventricular arrhythmias in anaesthetized CHF rats. However, Cav2.2-α shRNA failed to improve CHF-induced cardiac contractile dysfunction. Scrambled shRNA did not affect Cav2.2 currents and cell excitability of CSP neurons, CSNA, HRV, and ventricular arrhythmogenesis in CHF rats. Conclusions: Overactivation of Cav2.2 channels in CSP neurons contributes to cardiac sympathetic hyperactivation and ventricular arrhythmogenesis in CHF. This suggests that discovering purely selective and potent small-molecule Cav2.2 channel blockers could be a potential therapeutic strategy to decrease fatal ventricular arrhythmias in CHF.

Differential splicing patterns of L-type calcium channel Cav1.2 subunit in hearts of Spontaneously Hypertensive Rats and Wistar Kyoto Rats.

Smooth Muscle Tissues Express a Major Dominant Negative Splice Variant of the Type 3 Ca2+ Release Channel (ryanodine Receptor).

Aberrant Splicing Promotes Proteasomal Degradation Of L-Type Ca(V)1.2 Calcium Channels By Competitive Binding For Ca-V Beta Subunits In Cardiac Hypertrophy

Aberrant Splicing Promotes Proteasomal Degradation of L-type Ca V 1.2 Calcium Channels by Competitive Binding for Ca V β Subunits in Cardiac Hypertrophy

Molecular alteration of Ca v 1.2 calcium channel in chronic myocardial infarction

Alternative Splicing of Cav1.2 Channel Exons in Smooth Muscle Cells of Resistance-Size Arteries Generates Currents with Unique Electrophysiological Properties.

Losartan Reduced Connexin43 Expression in Left Ventricular Myocardium of Spontaneously Hypertensive Rats

Alterations in gene expression of calcium release channel in spontaneously hypertensive rats using RNA array

Alternative Splicing Generates a Novel Truncated Cav1.2 Channel in Neonatal Rat Heart

Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 Α1 Subunit

Smooth Muscle-Selective Alternatively Spliced Exon Generates Functional Variation In Ca(V)1.2 Calcium Channels

Exclusion of Alternative Exon 33 of Ca(V)1.2 Calcium Channels in Heart is Proarrhythmogenic

Characterization of CaV1.2 Exon 33 Heterozygous Knockout Mice and Negative Correlation Between Rbfox1 and CaV1.2 Exon 33 Expressions in Human Heart Failure

Alternative Splicing Modulates Diltiazem Sensitivity of Cardiac and Vascular Smooth Muscle Cav1.2 Calcium Channels

A Smooth Muscle Cav1.2 Calcium Channel Splice Variant Underlies Hyperpolarized Window Current and Enhanced State-Dependent Inhibition by Nifedipine.

Differential expression of TRPC channels in the left ventricle of spontaneously hypertensive rats

Functional Characterization of Alternative Splicing in the C Terminus of L-type CaV1.3 Channels.

Alternative Splicing at N Terminus and Domain I Modulates Ca(v)1.2 Inactivation and Surface Expression

CaV1.2 Channel N-terminal Splice Variants Modulate Functional Surface Expression in Resistance Size Artery Smooth Muscle Cells

Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure

The CaV1.2 Α1 Subunit N‐terminus Regulates Cerebral Artery Contractility